Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mind in Motion: Determining the Feasibility of a Mindfulness and Physical Activity Promotion Intervention After Anterior Cruciate Ligament Reconstruction

NCT07912502 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07912502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Mind in Motion: Determining the Feasibility of a Mindfulness and Physical Activity Promotion Intervention After Anterior Cruciate Ligament Reconstruction
Lead sponsor
University of Virginia
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 15, 2026
Completion date
December 31, 2027
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior cruciate ligament (acl) reconstruction

Arms

As registered; 1 arm.

  • Mind in Motion ExperimentalMind in Motion

    All enrolled participants receive the Mind in Motion intervention; there is no control or comparison arm. Over a 6-week home-based period, participants complete five 10-minute Headspace mindfulness sessions per week (drawn sequentially from the Basics, Sports Rehabilitation, and Sport Recovery courses) and wear an Oura Ring daily to receive a personalized daily moderate-to-vigorous physical activity (MVPA) goal, generated each day from the 60th percentile of the participant's own preceding 9 valid days of Oura-measured MVPA. Throughout the intervention, participants also complete brief twice-daily ecological momentary assessments of anticipated and experienced fear of movement, mood, soreness, and perceived exertion. The intervention is bracketed by two in-person visits (orientation/baseline and post-intervention) and includes a remote mid-intervention assessment and a remote 4-week post-intervention retention assessment.

Primary endpoints

Registered primary outcome measures; 5 primary.

  • Recruitment Rate Through completion of enrollment

    Proportion of prescreened, eligible individuals who consent and enroll in the study, calculated as the number of participants who sign informed consent/assent divided by the number who pass prescreening.

  • Retention Rate Baseline (Week 1) through Week 11

    Proportion of enrolled participants who complete the study through the Week 11 retention assessment. A pre-specified go/no-go benchmark of ≥85% retention was established.

  • Mindfulness Session Completion Weeks 2 through 7 (6-week intervention period)

    Percentage of prescribed Headspace mindfulness sessions (5 per week for 6 weeks; 30 total) completed per participant, captured via the Headspace API. A pre-specified go/no-go benchmark of ≥80%

  • Oura Ring Wear Adherence Weeks 2 through 7 (6-week intervention period)

    Percentage of intervention days with valid Oura Ring wear per participant. A pre-specified go/no-go benchmark of ≥80% of days was established.

  • Acceptability of Intervention Measure (AIM) Score Week 7 (post-intervention)

    Participant-rated acceptability of the Mind in Motion intervention, assessed using the 4-item Acceptability of Intervention Measure (scored 1-5; higher scores indicate greater acceptability). A pre-specified go/no-go benchmark of mean AIM ≥4.0 was established.

Lead sponsor's other trials

University of Virginia, most recent start first.